Search Results

<< Back to podcast list Dr. GPCR Podcast Strategic Partners Dr. GPCR Team About Dr. John Azietaku on the web LinkedIn Dr. GPCR About Ya-Tzu Li Ya-Tzu is a Master's student at the University of South Florida, utilizing large-scale In August, Ya-Tzu will continue her academic and research pursuits by beginning her PhD training in Medical Ya-Tzu Li on the web LinkedIn Dr.

<< Back to podcast list Dr. GPCR Podcast Strategic Partners Dr. Nicolas Gilles About Dr. His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations When the pharmacological properties of these new ligands are deemed exceptional, a lead optimization Nicolas Gilles on the web Google Scholar LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast? : The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific Journey Thanks for listening

Home → Flash News → Terry's Corner is Officially LIVE! TerrysCorner #DrugDiscovery Published on July 2, 2025 Category Terry's Corner Terry's Corner is Officially LIVE But what if the real opportunity lies in the chemical matter we throw at them?

For decades, molecular modeling focused on explaining — rationalizing why a ligand binds, why a mutation With tools like AlphaFold , his lab can now model receptor–peptide complexes in seconds — an achievement A good model doesn’t just match published structures; it forecasts new biology, new ligands, and new That’s where the future of GPCR research lies — not in describing the past, but in anticipating it.

Terry Kenakin in this 4-week immersive course covering ligand development & pharmacology. 🔹 What you – Renal & hepatic clearance, key pharmacokinetics ✅ PK-PD Modeling – Predicting drug behavior, non-linear Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. But what if the real opportunity lies in the chemical matter we throw at them?

announce our strategic partnership with Celtarys Research, a biotech company specializing in fluorescent ligand with Celtarys’ innovative chemical biology tools, making it easier than ever for scientists to study ligand-receptor announce our strategic partnership with Celtarys Research , a biotech company specializing in fluorescent ligand with Celtarys’ innovative chemical biology tools , making it easier than ever for scientists to study ligand-receptor But what if the real opportunity lies in the chemical matter we throw at them?

Rottapel’s research interests lies in the elucidation of signal transduction pathways in cancer, immune The Rottapel Lab Ontario Institute for Cancer Research University of Toronto Pubmed Google Scholar LinkedIn

Abhishek Kumar Singh Investigating The Role of ADGRB3 Loss of Expression in Brain Tumor Formation in Li-Fraumeni Scholar X (Twitter) Investigating The Role of ADGRB3 Loss of Expression in Brain Tumor Formation in Li-Fraumeni Syndrome Alex Torrelli-Diljohn Abstract "Li-Fraumeni syndrome (LFS) is a rare cancer predisposition Authors & Affiliations "Vukadin L, Park B, Mohamed M, Li H, Elkholy A, Torrelli-Diljohn A, Kim JH, Jeong He is interested in working on Li-Fraumeni syndrome and helping patients afflicted with this condition

<< Back to podcast list Dr. GPCR Podcast Strategic Partners Dr. Robert J. His legacy lies in the numerous discoveries he and his team made in the GPCR field and in all those who : The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific Journey Thanks for listening

But what if the real opportunity lies in the chemical matter we throw at them?

Michelle Halls unpacks how GPCR signaling isn’t just about ligand–receptor interaction. Michelle Halls unpacks how GPCR signaling isn’t just about ligand–receptor interaction. systems — where complexity is the key to precision. 🎧 Watch this moment from our conversation, then listen But what if the real opportunity lies in the chemical matter we throw at them?

But what if the real opportunity lies in the chemical matter we throw at them?

Back to schedule Trainee Symposium II Date & Time Thursday, November 2nd / 3:00 PM - 4:00 PM Title: Linking My primary research focus lies in gaining deeper insights into the structural mechanisms governing G protein engineering, receptor pharmacology, and structural biology to study how different types of ligands

2,3,*, Analisa Thompson Gray 2, Feyisayo Adegboye 2, Ainsley McDonald-Boyer 3, Fubiao Shi 1, Dianxin Liu 1, Jose Maldonado 5, Jiesi Feng 4, Yulong Li 4, Simon Alford 5, Julio E. The Department’s strengths lie in GPCR signal transduction and neuroscience, and she has expanded it She gave the Fritz Lipmann Lecture at ASBMB in 2001. " Heidi Hamm on the web The Hamm Lab Vanderbilt School of Medicine Pubmed Google Scholar LinkedIn Twitter Dr.

Their lab doesn’t just simulate receptor-ligand interactions after the fact; they aim to forecast receptor By integrating molecular docking, molecular dynamics, and machine learning, they design ligands with His team is candid about the limits of their models. This episode is essential listening for anyone thinking seriously about translational pharmacology and But what if the real opportunity lies in the chemical matter we throw at them?

. << Back to podcast list Dr. the IP-One kit, Tag-lite, and now, pH Sense. HTRF, the IP-One kit, and the Tag-lite platform into widespread use. His passion lies in turning cutting-edge probe chemistry into robust, scalable tools for drug discovery GPCR X Revvity Collaboration ⸻ Want more like this? Join the Dr.

. << Back to podcast list Dr. Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation What if the key to safer, more effective drugs lies is the heart of scientific innovation Who Should Listen PhD students and postdocs exploring biotech careers Seeing the limits of traditional drug discovery, he later co-founded Superluminal Medicines, a company Ajay Yekkirala on the web Superluminal Medicines LinkedIn Tune in now to hear how asking “what if?”

species, we plan to adapt this technology for high-throughput screening of pharmacological compound libraries Stephanie Häfner on the web LinkedIn Scholz Lab Langenhan Lab bioSens-All: A Multiparametric BRET-Based Authors & Affiliations "Ana Lilia Moreno Salinas (2), Arturo Mancini (1), Raida Jallouli (2), Richard My expertise lies in exploring the biological properties and signaling pathways activated by aGPCRs, Ana Lilia Moreno Salinas on the web ResearchGate LinkedIn < Previous Session Next Session >

< Back to Full Agenda Session II AGPCR signaling pathways and trafficking Localization of putative ligands ADGRG6 Drives Proteolytic Processing, Trafficking And Signalling Pal Kasturi Localization of putative ligands Yuling Feng on the web LinkedIn The ADGRF5/GPR116 receptor is a key regulator of lymphatic endothelial His research interest lies in understanding the molecular basis for human tumor development and how to ADGRG6 NTF has multiple extracellular domains like CUB, PTX, SEA, hormone binding domain, and the GAIN

Home → Flash News → Lighting up a native pancreatic islet isn’t just a technical win it’s a shift in what GPCR imaging can reveal Lighting up a native pancreatic islet isn’t just a technical win — it’s variability Surface-pool selectivity — the pharmacologically relevant population Compatibility with live takeaways you’ll want to steal. 🔗 Read the blog : https://www.ecosystem.drgpcr.com/post/when-the-islet-lit-up-advancing-gpcr-imaging-in-native-tissue

orthosteric vs allosteric function, and real vs apparent affinity • Molecular dynamics and how they guide ligand Kenakin Brief → https://www.terrykenakin.com #GPCRscience #drugdiscovery #TerrysCorner #GPCRpharmacology #ligandbinding orthosteric vs allosteric function, and real vs apparent affinity 🟢 Molecular dynamics and how they guide ligand Kenakin Brief → https://www.terrykenakin.com #GPCRscience #drugdiscovery #TerrysCorner #GPCRpharmacology #ligandbindingv

Home → Flash News → New biosensor technologies are shedding light on GPCR dynamics directly in cells, Published on October 24, 2024 Category GPCR Weekly News New biosensor technologies are shedding light

Terry Kenakin on May 1st, 2025, for an advanced live workshop on allosteric modulators in GPCR drug discovery Confirm allostery through kinetic analysis 📅 Date: May 1st, 2025 ⏳ Registration deadline: April 18th 📍 Live Terry Kenakin on May 1st, 2025 , for an advanced live workshop on allosteric modulators in GPCR drug Confirm allostery through kinetic analysis 📅 Date: May 1st, 2025⏳ Registration deadline: April 18th📍 Live

Tom Sakmar & Ilana Kotliar break down the link between GPCR autoantibodies, long COVID, and disease signaling in Ep.167 of the Dr.GPCR Podcast This episode is a must if you're thinking diagnostics. 📲 Tap to listen Tom Sakmar & Ilana Kotliar break down the link between GPCR autoantibodies, long COVID, and disease signaling in Ep.167 of the Dr.GPCR Podcast This episode is a must if you're thinking diagnostics. 📲 Tap to listen

🎧 Listen now: Ep 165 with Chuck DeWeese & Joe St. 🎧 Listen now: Ep 165 with Chuck DeWeese & Joe St.

🚀 Learn the practical issues with detecting, measuring, and quantifying GPCR ligand-biased signaling 🚀 Learn the practical issues with detecting, measuring, and quantifying GPCR ligand-biased signaling

Understanding receptor-specific nuances, like the role of NTF cleavage, is crucial for decoding their Understanding receptor-specific nuances, like the role of NTF cleavage, is crucial for decoding their

Listen to Ep.163 of the @DrGPCR Podcast, where @DVeprintsev shares his thoughts and experiences about Listen to Ep.163 of the @DrGPCR Podcast, where @DVeprintsev shares his thoughts and experiences about

City, Mexico October 23-25 Download PDF Program HERE < Back to Full Agenda Registration & Coffee with light

GPCR to expand fluorescent ligand tools for GPCR drug discovery, connecting biotech startups and scientists Learn more about new ligands and new GPCR behaviors that produce unique drug profiles. Learn more about new ligands and new GPCR behaviors that produce unique drug profiles. ✳️ Last chance